These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20080568)

  • 21. Homodimerization of the c-Abl protein tyrosine kinase.
    Wei L; Liu X; Yi YP; Li CF; Wang YL; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):698-702. PubMed ID: 16285507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ShcA regulates thymocyte proliferation through specific transcription factors and a c-Abl-dependent signaling axis.
    Trampont PC; Zhang L; Giles AJ; Walk SF; Gu JJ; Pendergast AM; Ravichandran KS
    Mol Cell Biol; 2015 Apr; 35(8):1462-76. PubMed ID: 25691660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Abelson tyrosine kinase (c-Abl) localization in preimplantation mouse development.
    Mutluay D; Oner H
    Rom J Morphol Embryol; 2017; 58(4):1385-1391. PubMed ID: 29556632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
    Goga A; Liu X; Hambuch TM; Senechal K; Major E; Berk AJ; Witte ON; Sawyers CL
    Oncogene; 1995 Aug; 11(4):791-9. PubMed ID: 7651743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage.
    Kharbanda S; Pandey P; Yamauchi T; Kumar S; Kaneki M; Kumar V; Bharti A; Yuan ZM; Ghanem L; Rana A; Weichselbaum R; Johnson G; Kufe D
    Mol Cell Biol; 2000 Jul; 20(14):4979-89. PubMed ID: 10866655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional screen for regulators of the c-Abl protein tyrosine kinase.
    Moro M; Walkenhorst J; Goga A; Witte ON; Superti-Furga G
    Leukemia; 1997 Apr; 11 Suppl 3():313-5. PubMed ID: 9209375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow B lymphocyte development in c-abl-deficient mice.
    Hardin JD; Boast S; Schwartzberg PL; Lee G; Alt FW; Stall AM; Goff SP
    Cell Immunol; 1995 Oct; 165(1):44-54. PubMed ID: 7671324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
    Welch PJ; Wang JY
    Cell; 1993 Nov; 75(4):779-90. PubMed ID: 8242749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance.
    Takao N; Mori R; Kato H; Shinohara A; Yamamoto Ki
    J Biol Chem; 2000 Jan; 275(2):725-8. PubMed ID: 10625600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical Cancer Growth Is Regulated by a c-ABL-PLK1 Signaling Axis.
    Yang X; Chen G; Li W; Peng C; Zhu Y; Yang X; Li T; Cao C; Pei H
    Cancer Res; 2017 Mar; 77(5):1142-1154. PubMed ID: 27899378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role and regulation of Abelson tyrosine kinase in Crk-associated substrate/profilin-1 interaction and airway smooth muscle contraction.
    Wang Y; Rezey AC; Wang R; Tang DD
    Respir Res; 2018 Jan; 19(1):4. PubMed ID: 29304860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine kinase c-Abl regulates the survival of plasma cells.
    Li YF; Xu S; Huang Y; Ou X; Lam KP
    Sci Rep; 2017 Jan; 7():40133. PubMed ID: 28057924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for c-Abl in c-myc regulation.
    Wong KK; Hardin JD; Boast S; Cooper CL; Merrell KT; Doyle TG; Goff SP; Calame KL
    Oncogene; 1995 Feb; 10(4):705-11. PubMed ID: 7862448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.
    He X; Zheng Z; Song T; Wei C; Ma H; Ma Q; Zhang Y; Xu Y; Shi W; Ye Q; Zhong H
    Oncogene; 2010 Apr; 29(15):2238-51. PubMed ID: 20101225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
    Fan PD; Cong F; Goff SP
    Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors.
    Theis S; Roemer K
    Oncogene; 1998 Aug; 17(5):557-64. PubMed ID: 9704921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts.
    Liberatore RA; Goff SP; Nunes I
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17823-8. PubMed ID: 19805123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell survival and function requires the c-Abl tyrosine kinase.
    Silberman I; Sionov RV; Zuckerman V; Haupt S; Goldberg Z; Strasser A; Ben-Sasson ZS; Baniyash M; Koleske AJ; Haupt Y
    Cell Cycle; 2008 Dec; 7(24):3847-57. PubMed ID: 19098427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
    Kain KH; Gooch S; Klemke RL
    Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.